# An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females

> **NCT06203444** · PHASE1 · COMPLETED · sponsor: **Ardelyx** · enrollment: 7 (actual)

## Conditions studied

- Lactation

## Interventions

- **DRUG:** Tenapanor

## Key facts

- **NCT ID:** NCT06203444
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-27
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06203444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06203444, "An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06203444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*